Federal Resources Supply Company was selected by the Defense Logistics Agency (DLA) to deliver kits of life-saving Personal Protective Equipment (PPE) to approximately 15,000 nursing homes across America. Responding to a request from the Federal Emergency Management Agency (FEMA) and in
Three Czech political figures have gone into hiding after it was believed they were being targeted by a Russian assasin in retaliation for affronts to Moscow.
It was reported that a Russian man had entered Prague a few weeks ago with an unspecified quantity of ricin in his
A new high-pressure ventilator developed by NASA engineers and tailored to treat coronavirus (COVID-19) patients today was approved by the Food and Drug Administration (FDA) for use under the FDA's ventilator Emergency Use Authorization.
Levrum has created a COVID-19 effects simulator to help organizations gauge the impacts of different epidemiology parameters for the pandemic on the organization’s ability to respond, based upon disease incidence
World-leading Manchester biotech researchers are working towards developing a test for COVID-19 that could be used at home like a domestic pregnancy test.
This prototype test is based on the fact sugars coat all human cells and could be used in the fight to detect infectious agents like
On April 21 a joint Air Force team, led by the Air Force Life Cycle Management Center and the Air Force’s CBRN Defense Systems Branch, delivered a rapidly developed containment system prototype that will enable as many as 28 COVID-positive patients to be transported aboard a C-17 in response to
Kromek, a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, is pleased to announce that it intends to commence the manufacture and sale of medical ventilators in the UK and globally under license from Metran Co., Ltd (“Metran”), a
A revolutionary decontamination system is being installed at Camp Murray, WA, which will be able to clean and sterilize up to 80,000 N95 respirator masks every day. This system is being called an exciting breakthrough that could help solve the shortage of masks for health care professionals
The University of Manchester is repurposing specialised equipment across its campus to help produce safety equipment for NHS workers battling COVID-19 in an attempt to help reduce the critical demand across the region.
In a combined effort with other universities, including Salford and
The Public Health Foundation has set up training related to Coronavirus Disease 2019 (COVID-19), available through the TRAIN Learning Network, a national learning network that aggregates training opportunities
From next week, two DRF Luftrettung stations in Germany will be using “EpiShuttles”, a special insulation stretcher. Another eight stations are to follow soon.
DRF Luftrettung invests in the protection of patients and their crews so that they can continue to help people in medical
GreyScan's Explosive Trace Device, the ETD-100, is a result of research by leading international Universities and scientists and forward thinking investors ($25M investment to date). The ETD-100 was deployed globally in 2020 to find trace substances, preventing a host of terrorist
Abbott has announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and
Biobeat, an end-to-end medical grade monitoring system for the management of patients and individuals from a distance is currently being utilised in 14 Israeli hospitals as the main monitoring solution in COVID-19 isolation units as part of the effort by the Israeli Ministry of Health to combat
U.S. Navy and Marine Corps service members in Guam were ordered on Wednesday to break their own quarantine to set up makeshift shelters for U.S. troops coming off a nuclear-powered aircraft carrier, where an outbreak of the novel coronavirus is rapidly
Nuclear scientists in Austria are closing in on coronavirus testing kits that could dramatically lower the cost and time it takes to diagnose people for the disease. With Covid-19 tests in short supply in many places, some individuals have turned to private
bioMérieux, a world leader in the field of in vitro diagnostics, today announced that its subsidiary, BioFire Defense, has received Emergency Use Authorization by the U.S. Food and Drug Administration of its BIOFIRE COVID-19 test for use in CLIA moderate and high complexity clinical
The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) and MatMaCorp completed a successful evaluation of a field-deployable genetic test to detect African Swine
The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) is conducting ongoing research that will help scientists better understand the coronavirus that causes the
We’ve been fairly quiet about COVID here, largely because any reporting is quickly over taken by events. Scientific advice has remained fairly consistent, but how that is applied nationally and the impact of rising rates of infection is hugely variable.
INOVIO Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it has received a new $5 million grant from the Bill & Melinda Gates Foundation to accelerate the testing and scale up of CELLECTRA® 3PSP proprietary smart device for the intradermal delivery of INO-4800, a DNA vaccine for
Coriolis µ is an innovative biological air sampler for bio-contamination assessment, mainly dedicated to air quality control and air quality monitoring in environmental and pollution research, the pharmaceutical, food and veterinary industries, in biomedical and health environments, and so on.
Merckhas confirmed that ERVEBO has now been registered by National Health Authorities in the following countries in Africa – DRC, Burundi, Ghana, and Zambia.
ERVEBO was granted a conditional marketing authorization by the European Commission on November 11, 2019 and approved by
Evidence Aid have been watching the progression of the Coronavirus. Because the outbreak is leading to a rapidly expanding and evolving literature, they have curated a page of entry points to this literature which you can see here: ...
Evidence Aid have been watching the progression of the Coronavirus. Because the outbreak is leading to a rapidly expanding and evolving literature, they have curated a page of entry points to this literature which you can see here: ...
The Public Health Agency of Canada is denying any connection between the National Microbiology Lab in Winnipeg, two scientists who were escorted out of the building last summer, and the coronavirus outbreak in China.
“What we have developed is like a living Velcro that removes and traps pathogens”
Nature-inspired wipes and masks which could capture and trap the Wuhan Coronavirus (2019-nCoV) are being developed by scientists at the Irish company Aquila Bioscience. This technology can be used
The M72/AS01E tuberculosis vaccine candidate demonstrated in a phase IIb trial the potential to reduce active pulmonary TB by half in adults with latent TB infection.
The Partnership for Research on Ebola Vaccination (PREVAC) has launched a project called PREVAC-UP with the aim of evaluating three Ebola vaccine regimens for five years after vaccination.
The study will assess several factors of these treaments
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, has announced that the Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response (ASPR),
Emergex Vaccines Holding Limited (‘Emergex’), a biotechnology company developing set-point vaccines to prevent serious infectious diseases, has announced the successful completion of the first step in the development of a candidate vaccine for the Gram-negative intracellular
Soligenix, Inc. has announced that it has opened the study titled "A Phase 1C, Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Safety of RiVax,
On Tuesday December 3rd a patient was admitted to a specialist unit at St Thomas' Hospital in central London after Public Health England confirmed a diagnosis of Monkeypox.
It is believed the individual contracted the virus whilst visting Nigeria, which has seen at least four
SIGA Technologies, Inc. today announced that the Canadian Department of National Defence (CDND) has issued an advanced contract award notice (ACAN), indicating that it intends to award a contract to fund regulatory filing with Health Canada for approval of oral TPOXX®.
Merck , known as MSD outside the United States and Canada, today announced that the European Commission has granted a conditional marketing authorization to ERVEBO for active immunization of individuals 18 years of age or older to protect against Ebola Virus Disease (EVD) caused by Zaire Ebola
GlaxoSmithKline plc has announced the divestment of travel vaccines Rabipur (tradename Rabavert in the US) for the prevention of rabies, and Encepur for the prevention of tick-borne encephalitis, to Bavarian Nordic.
The decision to divest these brands, acquired from Novartis in 2015 as
Porton Biopharma Ltd (PBL) has today announced that it has signed a modification to its contract (HHSN272201600045C) with the US National Institute of Health’s National Institute of Allergy and Infectious Diseases
The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on Thursday allowed the marketing of the first rapid diagnostic test for the Ebola virus that has not been authorized via the agency’s Emergency Use Authorization (EUA) pathway.
The Sabin Vaccine Institute (Sabin) has announced a funding award of $20.5 million with options for an additional $107.5 million from the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services. Under the terms of this agreement,
SIGA Technologies, Inc. announced on October 3rd that it has reached concurrence with the US Food and Drug Administration (FDA) that no further clinical studies will be required for the IV formulation of TPOXX (tecovirimat), and SIGA anticipates filing the New Drug Application (NDA) for this
...
Our Current Partners
How to resolve AdBlock issue?
Action 1: Action 1: You are using adblocker please support us by whitelisting this domain - https://cbrneworld.com/